Zoomedia Blog
All Blogs:
On July 29, 2010, the FDA issued a warning letter to Novartis stating that content shared through Facebook and ShareThis functionality "... is misleading because it makes representations about the efficacy of Tasigna but fails to communicate any risk information associated with the use of this drug. In addition, the shared content inadequately communicates Tasigna’s FDA-approved indication and implies superiority over other products."
Tags: FDA, regulatory, warning letter, social media, Facebook
One of the most successful social media campaigns to date has just made its run – and Old Spice is suddenly hip again. So, what has made this campaign so successful and what can biotech and pharma learn from it? Here are a few reasons why we think it worked so well...
Tags: YouTube, social media
The last few months have seen awards for three Zoomedia clients Cell Therapeutics, Codexis, and Ventus. Read more about what they won!
Tags: Awards
The last few months have seen awards for three Zoomedia clients, the most recent of which went to Cell Therapeutics for an Investor awareness campaign developed by Zoomedia. CTI was awarded second place in the Branding & Marketing category of NIRI Seattle Annual Investor Communications Awards...
CTI Investor awareness campaign developed by Zoomedia wins second place in Branding & Marketing category of NIRI Seattle Annual Investor Communications Awards. Judges commented that...
Tags: investor strategies
